Dexamethasone phosphate "hameln" 4 mg/ml injektionsvæske, opløsning Dania - duński - Lægemiddelstyrelsen (Danish Medicines Agency)

dexamethasone phosphate "hameln" 4 mg/ml injektionsvæske, opløsning

hameln pharma gmbh - dexamethasonnatriumphosphat - injektionsvæske, opløsning - 4 mg/ml

Apexxnar Unia Europejska - duński - EMA (European Medicines Agency)

apexxnar

pfizer europe ma eeig - pneumococcal polysaccharide serotype 1, pneumococcal polysaccharide serotype 3, pneumococcal polysaccharide serotype 4, pneumococcal polysaccharide serotype 5, pneumococcal polysaccharide serotype 6a, pneumococcal polysaccharide serotype 6b, pneumococcal polysaccharide serotype 7f, pneumococcal polysaccharide serotype 8, pneumococcal polysaccharide serotype 9v, pneumococcal polysaccharide serotype 10a, pneumococcal polysaccharide serotype 11a, pneumococcal polysaccharide serotype 12f, pneumococcal polysaccharide serotype 14, pneumococcal polysaccharide serotype 15b, pneumococcal polysaccharide serotype 18c, pneumococcal polysaccharide serotype 19a, pneumococcal polysaccharide serotype 19f, pneumococcal polysaccharide serotype 22f, pneumococcal polysaccharide serotype 23f, pneumococcal polysaccharide serotype 33f - pneumokokinfektioner - vacciner - active immunisation for the prevention of invasive disease and pneumonia caused by streptococcus pneumoniae in individuals 18 years of age and older. se afsnit 4. 4 og 5. 1 for information om beskyttelse mod specifikke pneumokokserotyper. apexxnar should be used in accordance with official recommendations. .

Tecvayli Unia Europejska - duński - EMA (European Medicines Agency)

tecvayli

janssen-cilag international n.v. - teclistamab - multipelt myelom - antineoplastiske midler - tecvayli is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.

Columvi Unia Europejska - duński - EMA (European Medicines Agency)

columvi

roche registration gmbh  - glofitamab - lymphoma, large b-cell, diffuse - antineoplastiske midler - columvi as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl), after two or more lines of systemic therapy.

Talvey Unia Europejska - duński - EMA (European Medicines Agency)

talvey

janssen-cilag international n.v. - talquetamab - multipelt myelom - antineoplastiske midler - talvey is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least 3 prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti cd38 antibody and have demonstrated disease progression on the last therapy.

Metex Pen 10 mg injektionsvæske, opløsning i fyldt pen Dania - duński - Lægemiddelstyrelsen (Danish Medicines Agency)

metex pen 10 mg injektionsvæske, opløsning i fyldt pen

medac, gesellschaft für klinische spezialpräparate mbh - methotrexatnatrium - injektionsvæske, opløsning i fyldt pen - 10 mg

Metex Pen 12,5 mg injektionsvæske, opløsning i fyldt pen Dania - duński - Lægemiddelstyrelsen (Danish Medicines Agency)

metex pen 12,5 mg injektionsvæske, opløsning i fyldt pen

medac, gesellschaft für klinische spezialpräparate mbh - methotrexatnatrium - injektionsvæske, opløsning i fyldt pen - 12,5 mg

Metex Pen 15 mg injektionsvæske, opløsning i fyldt pen Dania - duński - Lægemiddelstyrelsen (Danish Medicines Agency)

metex pen 15 mg injektionsvæske, opløsning i fyldt pen

medac, gesellschaft für klinische spezialpräparate mbh - methotrexatnatrium - injektionsvæske, opløsning i fyldt pen - 15 mg

Metex Pen 17,5 mg injektionsvæske, opløsning i fyldt pen Dania - duński - Lægemiddelstyrelsen (Danish Medicines Agency)

metex pen 17,5 mg injektionsvæske, opløsning i fyldt pen

medac, gesellschaft für klinische spezialpräparate mbh - methotrexatnatrium - injektionsvæske, opløsning i fyldt pen - 17,5 mg

Metex Pen 20 mg injektionsvæske, opløsning i fyldt pen Dania - duński - Lægemiddelstyrelsen (Danish Medicines Agency)

metex pen 20 mg injektionsvæske, opløsning i fyldt pen

medac, gesellschaft für klinische spezialpräparate mbh - methotrexatnatrium - injektionsvæske, opløsning i fyldt pen - 20 mg